MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Malvidin-3-galactoside chloride

CAS No. : 30113-37-2

MCE 站：Malvidin-3-galactoside chloride

产品活性：Malvidin-3-galactoside chloride 是一种花青素单体，可诱导肝细胞癌 (HCC) 细胞周期停滞和凋亡。Malvidin-3-galactoside chloride 抑制 ROS 的产生和积累。Malvidin-3-galactoside chloride 具有抗肿瘤功能。

研究领域：Apoptosis  |  Protein Tyrosine Kinase/RTK

作用靶点：Apoptosis  |  ROS

In Vitro: Malvidin-3-galactoside chloride (50, 100, 200 μg/mL; for 24, 48, 72 h) displays obvious cytotoxicity on Huh-7 cells ａnd has no significant effect with 50 ａnd 100 μg/mL for 48 h. Malvidin-3-galactoside chloride has a notable cytotoxic effect against Huh-7 cells at 72 h.
Malvidin-3-galactoside chloride (50-200 μg/mL) arrests the cells in the S phase, accompanied by the cells in the G1 phase decreased, ａnd the cells in the S phase increased.
Malvidin-3-galactoside chloride (50-200 μg/mL; for 72 h) induces cell apoptosis in Huh-7 cells.
Malvidin-3-galactoside chloride (50-200 μg/mL; for 72 h) markedly increased the levels of caspase-3, cleaved-caspase-3 ａnd cleaved-PARP in a dose-dependent manner.
Malvidin-3-galactoside chloride (50-200 μg/mL; for 12 h) inhibits the production ａnd accumulation of ROS.
Malvidin-3-galactoside chloride (50-200 μg/mL; for 12 h) dramatically reduces the level of phosphorylation ERK (p-ERK) in a dose-dependent manner. Malvidin-3-galactoside chloride with 200 μg/mL markedly increases the phosphorylation level of p38 ａnd JNK (p-p38 ａnd p-JNK).
Malvidin-3-galactoside chloride (50-200 μg/mL; for 12 h) inhibits the migration ａnd invasion in Huh-7 cells.

相关产品：MG-132  |  LY294002  |  Doxorubicin hydrochloride  |  Bafilomycin A1  |  Y-27632 dihydrochloride  |  Paclitaxel  |  Acetylcysteine  |  Angiotensin II human  |  Staurosporine  |  Bortezomib  |  5-Fluorouracil  |  Sorafenib  |  Tamoxifen  |  SP600125  |  Trametinib  |  2-Deoxy-D-glucose  |  Gemcitabine  |  Temozolomide  |  MK-2206 dihydrochloride  |  Verteporfin  |  Decitabine  |  Actinomycin D  |  Etoposide  |  Pexidartinib  |  BAY 11-7082  |  CCCP  |  DAPT  |  Ruxolitinib  |  Mitomycin C

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。